● Covered by 1 source · 1 reportMedium impact1 neutral
Former OpenAI Science Lead Launches Warp Science with $215M to Automate Drug Discovery Labs
Key points
- Kevin Weil launched Warp Science, an AI startup.
- Warp Science raised $215 million at an $865 million valuation.
- The company automates wet lab work for drug discovery.
- Robots will be trained by human chemists to perform lab tasks.
Startup Launch and Funding
Kevin Weil, previously a science lead at OpenAI, has launched a new AI startup named Warp Science. The company focuses on automating lab processes for drug discovery.
Warp Science announced it has secured $215 million in funding, valuing the company at $865 million. The funding round was led by Lightspeed, with additional participation from IVP, Premji Invest, and Lux Capital.
Automating Lab Work
Warp Science's core function involves training robots to synthesize and test chemical compounds identified by researchers. Human chemists will use cameras and sensor gloves to train these robots to perform various lab tasks.
The goal of this automation is to accelerate drug discovery by enabling robots to operate continuously, around the clock.
Addressing Supply Chain Risks
Weil stated that Warp Science aims to reshore labor-intensive lab work, which has historically been outsourced to contractors in countries like China, such as WuXi AppTec. This initiative seeks to insulate the drug development process from geopolitical supply-chain risks.
✨ This summary was generated by AI from the outlets' reporting listed below. It is not independently verified and may contain errors — check the original sources. How BrevFeed works →
The daily brief
One email each morning: the day's tech stories, clustered across outlets and summarized. No account needed.
One email a day. Unsubscribe in one click, any time.
Today's brief
Spend a few minutes, get the whole day. Every topic's top stories in one hands-free rundown — listen, watch, or read the transcript.
▶ Play today's brief
New every morning, and the back catalogue is archived by date.
Reporting from
Kevin Weil, former OpenAI science lead, launched Warp Science, an AI startup automating wet lab work for drug discovery. The company raised $215 million at an $865 million valuation to train robots for synthesizing and testing compounds, aiming to reshore lab work and accelerate drug development.